Hepatitis C virus Core Antigen as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon α-2b plus ribavirin
Open Access
- 1 March 2004
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 40 (3) , 527-532
- https://doi.org/10.1016/j.jhep.2003.11.026
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Prediction of Treatment Outcome in Patients With Chronic Hepatitis C: Significance of Baseline Parameters and Viral Dynamics During TherapyHepatology, 2003
- National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C 2002 (June 10–12, 2002)Gastroenterology, 2002
- Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD)Journal of Hepatology, 2002
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002
- Molecular diagnosis of viral hepatitisGastroenterology, 2002
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialPublished by Elsevier ,2001
- Is an “à la carte” combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C?Hepatology, 2000
- Early predictors of response to treatment in patients with chronic hepatitis CJournal of Hepatology, 1999
- Quantification of the initial decline of serum hepatitis c virus RNA and response to interferon alfaHepatology, 1998
- Serum Levels of Hepatitis C Virus Core Protein in Patients With Chronic Hepatitis C Treated With Interferon AlfaHepatology, 1996